drugset / Trial / NCT00571805

Study of Varencline Effects on Cigarette Smoking Reward and Craving During a Model of Brief Quit Attempt

NCT00571805

Phase 1/2 Withdrawn NYU Langone Health Pfizer · collab
RandomizedParallel-groupQuadruple-blind

Summary

Study of varenicline 2.0 mg/day treatment for 2 weeks with smoking test done in laboratory on Day 8 and a 1 week quit attempt from Day 8-14.

Timeline

Start
2007-09
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Varenicline Small molecule 2 mg

Indications